Moreover, TEL effectively attenuated the increase in Aβ-induced expression of cytokines in animal models of AD [31, 83], where these anti-inflammatory effects were reversed by the PPARγ antagonist, GW9662. This evidence concerns the gene PPARG and Alzheimer disease.